Trial Profile
A Study to Evaluate Whether Sirolimus-Eluting Stent (SES) Implantation Exerts an Antiproliferative Action on Bare Metal Stent (BMS) Placed Distally in the Same Coronary Artery
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 May 2016
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Ischaemic heart disorders
- Focus Therapeutic Use
- 26 May 2016 New trial record